| 3.8 |
11.3 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.5 |
7.5 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 1.4 |
4.3 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.2 |
3.7 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.0 |
4.1 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.9 |
2.7 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.9 |
3.6 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 0.9 |
4.4 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.9 |
3.4 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.8 |
4.7 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.8 |
5.5 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.7 |
0.7 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.7 |
2.8 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
| 0.7 |
0.7 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.7 |
3.4 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.6 |
1.9 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.6 |
1.9 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.6 |
1.9 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.6 |
2.5 |
GO:0050923 |
regulation of negative chemotaxis(GO:0050923) |
| 0.6 |
1.8 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.6 |
1.8 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.6 |
1.8 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.6 |
1.2 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.6 |
1.7 |
GO:0046959 |
habituation(GO:0046959) |
| 0.6 |
1.1 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.6 |
2.8 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.6 |
2.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.5 |
3.2 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) protein localization to ciliary transition zone(GO:1904491) |
| 0.5 |
3.9 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.5 |
1.5 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.5 |
2.4 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.5 |
1.9 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.4 |
1.3 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.4 |
1.3 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.4 |
3.3 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.4 |
1.2 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.4 |
1.6 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.4 |
1.9 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.4 |
1.1 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.4 |
1.1 |
GO:0038095 |
positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.4 |
0.7 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.4 |
1.5 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.4 |
1.5 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.4 |
1.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
1.8 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.4 |
1.1 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.3 |
1.0 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.3 |
0.7 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.3 |
1.0 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
0.3 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.3 |
1.0 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 |
1.0 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 |
1.6 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
1.0 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.3 |
0.9 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.3 |
0.3 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 |
1.8 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
1.2 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.3 |
1.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.3 |
1.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 |
4.0 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 |
1.6 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.3 |
6.3 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.3 |
1.9 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.3 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.3 |
0.8 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.3 |
0.3 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
0.8 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.3 |
1.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.3 |
1.0 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
1.2 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
0.7 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 |
4.0 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 |
0.7 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.2 |
3.5 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.2 |
1.8 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 |
2.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
0.7 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.2 |
8.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.2 |
1.8 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 |
0.4 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 0.2 |
0.7 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 |
1.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
0.7 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
1.9 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
1.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.2 |
0.6 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.2 |
1.9 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.2 |
0.6 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
1.4 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.2 |
0.6 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.2 |
1.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
0.6 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
0.8 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.2 |
0.6 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.2 |
0.8 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.2 |
0.8 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.4 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.2 |
0.8 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
0.6 |
GO:0033364 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) mast cell secretory granule organization(GO:0033364) |
| 0.2 |
0.2 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 0.2 |
0.2 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.2 |
0.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.2 |
0.4 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.2 |
0.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.9 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.2 |
0.7 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.2 |
0.4 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.2 |
0.5 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
0.5 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
0.2 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 0.2 |
0.3 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 |
0.2 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.2 |
0.7 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.2 |
0.2 |
GO:0060067 |
cervix development(GO:0060067) |
| 0.2 |
1.5 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.2 |
0.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 |
1.1 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
2.6 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
1.1 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.2 |
0.5 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.2 |
0.2 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.2 |
0.5 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.2 |
0.5 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.2 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
1.2 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.1 |
0.4 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.4 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.1 |
0.7 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 |
0.9 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.6 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.3 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
0.3 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.7 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) |
| 0.1 |
0.7 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.1 |
0.9 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.1 |
0.4 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.3 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.1 |
0.7 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
1.3 |
GO:0098739 |
import across plasma membrane(GO:0098739) |
| 0.1 |
1.3 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 0.1 |
0.8 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
1.4 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.4 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.1 |
0.3 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
0.4 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.8 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.4 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.8 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.5 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.7 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.1 |
0.5 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.1 |
0.7 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.1 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
0.4 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.7 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.6 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.4 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
0.4 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.9 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.1 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.1 |
0.8 |
GO:0030825 |
positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.5 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.1 |
0.5 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.6 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
1.7 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
1.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.9 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.1 |
0.2 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
0.8 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
1.7 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 |
1.7 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
0.9 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
0.8 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.3 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
1.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.2 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.1 |
0.3 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.2 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.1 |
4.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.4 |
GO:1900157 |
regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 0.1 |
0.9 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.9 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.5 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.6 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.9 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 |
0.5 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.1 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.3 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.1 |
1.7 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.4 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
1.3 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
1.5 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.1 |
0.2 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
0.2 |
GO:0098910 |
regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.8 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.1 |
0.3 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
0.3 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.2 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.8 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.8 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.7 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.4 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.1 |
0.4 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
1.3 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 |
0.5 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.1 |
0.7 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
1.0 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.1 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
1.5 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
1.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.9 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.4 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.4 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.2 |
GO:0003211 |
cardiac ventricle formation(GO:0003211) |
| 0.1 |
0.1 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
0.9 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
1.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.7 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.5 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.3 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.6 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.9 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.3 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.3 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.2 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.1 |
0.6 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
0.6 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.3 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.1 |
0.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.2 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.1 |
0.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.1 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 |
0.3 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.1 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 |
0.1 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.1 |
0.1 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 |
1.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.1 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.1 |
0.7 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.1 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.7 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.1 |
0.3 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.5 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.3 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.3 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.1 |
0.3 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.1 |
1.3 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.1 |
0.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.1 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.1 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
1.2 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.4 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.1 |
0.4 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.9 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.1 |
0.2 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
0.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
1.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.2 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
0.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.1 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 |
0.2 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
0.5 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 |
0.1 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 |
0.5 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.3 |
GO:0051012 |
microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.1 |
0.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
1.0 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.3 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glycolytic process through glucose-1-phosphate(GO:0061622) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
4.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.2 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 |
0.1 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.1 |
0.2 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 |
1.9 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.1 |
1.9 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.1 |
0.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.4 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.1 |
0.5 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 |
0.2 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.1 |
0.3 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
0.1 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
0.1 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.2 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 |
0.2 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.3 |
GO:0086064 |
cell communication by electrical coupling involved in cardiac conduction(GO:0086064) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.1 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
1.0 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.2 |
GO:1990481 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) snRNA pseudouridine synthesis(GO:0031120) mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.1 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.2 |
GO:2000110 |
protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
1.0 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.3 |
GO:1900086 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.1 |
1.4 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 |
0.3 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.2 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 |
0.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.2 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
0.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
1.4 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.1 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.0 |
0.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.7 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.1 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.0 |
0.8 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.0 |
0.7 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.5 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.0 |
0.3 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.1 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.0 |
0.9 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 |
0.6 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.0 |
0.4 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.2 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 |
0.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.3 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.0 |
3.0 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.4 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.0 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.0 |
1.4 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.1 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.0 |
0.2 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.6 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.0 |
0.1 |
GO:0002467 |
germinal center formation(GO:0002467) regulation of germinal center formation(GO:0002634) positive regulation of germinal center formation(GO:0002636) |
| 0.0 |
0.3 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.5 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.0 |
0.8 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 |
0.3 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.3 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
1.6 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.2 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.3 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 0.0 |
0.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.3 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.0 |
0.3 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) |
| 0.0 |
0.0 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.2 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.0 |
0.2 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
4.8 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.0 |
0.4 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 |
0.3 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.1 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 |
0.1 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
1.1 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.4 |
GO:2000480 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.5 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.8 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.2 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.0 |
0.2 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.3 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.3 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.0 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.3 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.2 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 |
0.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
2.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.8 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.4 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.0 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 0.0 |
0.3 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
0.1 |
GO:0039521 |
suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
| 0.0 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.0 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
0.2 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
1.3 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
1.7 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.0 |
1.4 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.0 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.1 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.0 |
0.3 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.1 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.1 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.0 |
0.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.3 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.1 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.1 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.0 |
0.5 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.6 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:0090281 |
negative regulation of calcium ion import(GO:0090281) |
| 0.0 |
0.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 |
0.3 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.1 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.0 |
0.4 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.0 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
| 0.0 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.1 |
GO:0042511 |
positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.0 |
0.1 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.0 |
0.1 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.0 |
0.7 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.4 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.1 |
GO:0070572 |
positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 |
0.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.8 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.3 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 |
0.2 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 |
0.0 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.0 |
0.0 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.1 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.0 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.0 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 |
0.1 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.2 |
GO:0060049 |
regulation of protein glycosylation(GO:0060049) |
| 0.0 |
0.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.0 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.0 |
0.1 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.3 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 |
0.1 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.0 |
1.6 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.0 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.0 |
0.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.1 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.0 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
0.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.0 |
0.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.0 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.0 |
0.0 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.2 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 |
0.1 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.0 |
0.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.3 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.0 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.0 |
0.1 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 |
0.1 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
1.9 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.2 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 |
0.4 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.1 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.0 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.0 |
0.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.2 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
1.4 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.1 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.0 |
0.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 |
0.1 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.0 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.5 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.0 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.2 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.2 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.2 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.0 |
0.1 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.1 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.0 |
GO:0060444 |
branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.0 |
0.1 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.0 |
0.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0051403 |
stress-activated MAPK cascade(GO:0051403) |
